| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Futura Medical PLC - Holding(s) in Company | - | RNS | ||
| Di | Futura Medical PLC - PDMR Dealing | 20 | RNS | ||
| Mo | Futura Medical PLC - Holding(s) in Company | - | RNS | ||
| 24.09. | Futura Medical PLC - Rule 2.9 Announcement | 1 | RNS | ||
| FUTURA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 24.09. | Futura Medical PLC - Correction: Result of GM and Total Voting Rights | 1 | RNS | ||
| 24.09. | Futura Medical PLC - Result of General Meeting and Total Voting Rights | 1 | RNS | ||
| 17.09. | Futura Medical PLC - Holding(s) in Company | 3 | RNS | ||
| 10.09. | Futura Medical PLC - Board Change | 1 | RNS | ||
| 09.09. | Futura Medical PLC - Rule 2.9 Announcement | 2 | RNS | ||
| 07.09. | Futura Medical PLC - Oversubscribed Retail Offer | - | RNS | ||
| 04.09. | Futura Medical schedules shareholder meeting for Sept. 23 | 1 | Investing.com | ||
| 04.09. | Futura Medical PLC - Posting of Circular and Notice of General Meeting | - | RNS | ||
| 03.09. | TRADING UPDATES: Futura Medical's fundraise and formal sale process | 1 | Alliance News | ||
| 03.09. | Futura Medical PLC - Retail Offer via the BookBuild Platform | 9 | RNS | ||
| 03.09. | Futura Medical PLC - Fundraise and launch of FSP and M&A process | 1 | RNS | ||
| 01.09. | Futura Medical H1 Loss Decreases | 1 | RTTNews | ||
| 01.09. | Futura Medical PLC - Unaudited Interim Results 2026 | - | RNS | ||
| 12.08. | AIM Market Roundup: Focus Xplore, Futura Medical, Bravura Solutions | 2 | The Armchair Trader | ||
| 31.07. | Futura Medical erhält EU-Zulassung für Eroxon Intense Gel | 4 | Investing.com Deutsch | ||
| 31.07. | Futura Medical receives EU clearance for Eroxon Intense gel | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 33,370 | -1,81 % | Nur noch 4 Spritzen im Jahr?: Dieser Novo-Deal lässt eine kleine Pharma-Aktie um bis zu 161 % explodieren | © Foto: Steffen Trumpf - dpaNovo Nordisk sichert sich exklusiv eine Technologie, die Adipositas- und Diabetesmedikamente künftig deutlich seltener nötig machen könnte. Für Nanexa wird der Deal zum Börsenfeuerwerk... ► Artikel lesen | |
| GILEAD SCIENCES | 131,18 | -0,05 % | Assembly Biosciences: Herpes-Countdown mit Gilead | ||
| AURORA CANNABIS | 3,452 | -0,92 % | Aurora Cannabis: Beschwerde bringt den Deal ins Wanken | ||
| CANOPY GROWTH | 0,772 | -2,01 % | Canopy Growth Corporation: Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany | Mr. Blöte's appointment strengthens Canopy Growth's commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or... ► Artikel lesen | |
| TILRAY BRANDS | 3,135 | -1,10 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 451,80 | +0,22 % | $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | ||
| INNOCAN PHARMA | 1,270 | +0,79 % | Innocan Pharma Corporation: VALITIC Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA | HERZLIYA, Israel and CALGARY, Alberta, Sept. 29, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), through B.I. Sky Global Ltd., its consumer... ► Artikel lesen | |
| BIOTEST | 33,200 | 0,00 % | Osborne Clarke berät Grifols S.A. bei der Umwandlung der Biotest AG in eine GmbH & Co. KGaA | ||
| CRONOS GROUP | 2,840 | -0,77 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 0,931 | -0,53 % | Original-Research: SYNBIOTIC SE (von NuWays AG): Under review | Original-Research: SYNBIOTIC SE - from NuWays AG
24.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| DIGICANN VENTURES | 0,010 | -24,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 2,900 | +0,69 % | XFRA PV3B: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EDWARDS LIFESCIENCES | 75,54 | -0,34 % | Edwards Lifesciences Q2 Profit Down; Raises 2026 Sales Outlook | WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) on Thursday reported a lower profit in the second quarter, as revenues increased 14%.Net income declined to $241.9 million or $0.42 per... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,910 | +4,12 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 5,940 | -1,49 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen |